Weekly gemcitabine (GEM) and 5-fluorouracil (5-FU) in pancreatic carcinoma. Phase I-II study

被引：1
|
作者：
Tarantini, P [1 ]
Corsi, DC [1 ]
Cassano, A [1 ]
Pozzo, C [1 ]
Angelelli, L [1 ]
Signorelli, C [1 ]
Specchia, M [1 ]
Barone, C [1 ]
机构：
[1] Univ Cattolica Sacro Cuore, Rome, Italy
来源：
EUROPEAN JOURNAL OF CANCER | 1999年 / 35卷
关键词：
D O I：
10.1016/S0959-8049(99)81010-7
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
582
引用
收藏
页码：S156 / S156
页数：1
相关论文
共 50 条
  • [1] Gemcitabine (GEM) and 5-fluorouracil (5 FU) in advanced pancreatic cancer: A GISCAD phase II study
    Cascinu, S
    Frontini, L
    Labianca, R
    Silva, R
    Ferretti, B
    Barni, S
    Catalano, G
    Cellerino, R
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 1268 - 1268
  • [2] Phase I-II study of gemcitabine (GEM) in combination with 24 hours continuous infusion (CI) of 5-fluorouracil (5-FU) and leucovorin (LV) in patients (pts) with advanced pancreatic carcinoma (APC).
    Lencioni, M
    Falcone, A
    Masi, G
    Fioretto, L
    Di Marsico, R
    Pfanner, E
    Fontana, E
    Galli, C
    Bonifazi, V
    Conte, PF
    ANNALS OF ONCOLOGY, 2000, 11 : 66 - 66
  • [3] Weekly gemcitabine and 24-hour infusional 5-fluorouracil in advanced pancreatic cancer: A phase I-II study
    Barone, C
    Cassano, A
    Corsi, DC
    Pozzo, C
    Longo, R
    Schinzari, G
    Quirino, M
    Battelli, C
    Basso, M
    ONCOLOGY, 2003, 64 (02) : 139 - 145
  • [4] Phase II study of oxaliplatin (OX), 5-fluorouracil (5-FU), and radiation therapy (RT) followed by gemcitabine (GEM) in patients with unresectable pancreatic cancer
    Kim, G. P.
    Haddock, M.
    Foster, N. R.
    Bollinger, J.
    Stella, P. J.
    Kugler, J. W.
    Alberts, S. R.
    Martenson, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [5] Phase II study with weekly 24-h infusion of high-dose 5-fluorouracil (5-FU) and gemcitabine (GEM) in metastatic pancreas cancer
    Wein, A
    Wehler, M
    Fischer, B
    Boxberger, F
    Lampert, S
    Riedel, C
    Kastl, S
    Hohenberger, W
    Hahn, EG
    Schneider, T
    GASTROENTEROLOGY, 2001, 120 (05) : A612 - A612
  • [6] Phase II study of weekly high-dose infusional (HD-CI) 5-fluorouracil (5-FU) in advanced pancreatic carcinoma
    Lutz, MP
    Koniger, M
    Muche, R
    Adler, G
    Gress, TM
    ANNALS OF ONCOLOGY, 1998, 9 : 54 - 54
  • [7] Phase I-II study of gemcitabine (GEM) plus fluorouracil (5-FU) and folinic acid (FA) in patients with advanced breast cancer (ABC).
    Simoncini, E
    Ferrari, VD
    Marpicati, P
    Montini, E
    Rangoni, G
    Marini, G
    ANNALS OF ONCOLOGY, 2000, 11 : 42 - 42
  • [8] FOLINIC ACID (FA) AND 5-FLUOROURACIL (5-FU) - PHASE-I-II STUDY
    CUNNINGHAM, JR
    BUKOWSKI, RM
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1983, 33 (02) : 221 - 221
  • [9] Phase I-II trial of weekly gemcitabine plus high-dose 5-fluorouracil and leucovorin in advanced pancreatic cancer
    Shiah, HS
    Cheng, AL
    Hsu, C
    Hsu, CH
    Liu, TW
    Chang, JY
    Jan, CM
    Chao, Y
    Yu, WL
    Chuang, TR
    Whang-Peng, J
    Chen, LT
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 (03) : 531 - 536
  • [10] Gemcitabine and continuous infusion of 5-fluorouracil in locally advanced and metastatic pancreatic cancer: A phase I-II study
    Oliani, C
    Padovani, M
    Manno, P
    Barana, D
    Falconi, M
    Bassi, C
    Cavallini, G
    Pederzoli, P
    Cetto, GL
    ANTICANCER RESEARCH, 2004, 24 (3B) : 2107 - 2112
12345